Drug intelligence / Profile preview

CTD-2292M14.1

Development stage
Preclinical
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

CTD-2292M14.1 is a novel long non-coding RNA (lncRNA) identified as a key mediator of radioresistance in cervical cancer. While typically expressed at low levels in cervical cancer tissues, its expression is significantly upregulated following ionizing radiation, which correlates with poor patient prognosis. Mechanistically, CTD-2292M14.1 interacts with the p62 protein (encoded by the SQSTM1 gene), facilitating its ubiquitination and subsequent proteasomal degradation. The resulting loss of p62 protein enhances cellular autophagy and suppresses radiation-induced ferroptosis, thereby protecting cervical cancer cells from DNA damage and apoptosis. Therapeutic strategies aimed at knocking down CTD-2292M14.1 or targeting the CTD-2292M14.1-p62 axis are being investigated to overcome radioresistance and sensitize tumors to radiotherapy.

02

Targets

SQSTM1 (Sequestosome-1)

Beyond the preview

Go deeper on CTD-2292M14.1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTD-2292M14.1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call